Victoria Johnson

In other populations, JAKis demonstrated at least a similar pain benefit to b/tsDMARDs from baseline.

Calabrese discussed factors for rheumatologists to keep in mind, including recent travel and screening for viral infections.

Higher Life’s Essential 8 score was associated with higher CVH scores in US adults.

Younger people and people without European origin were less likely to adhere to urate-lowering therapy.

There were no differences in the treatment effect of ertugliflozin on gout-related outcomes in subgroups based on eric acid quintile or other baseline characteristics.

Further data will be presented at the 2024 AANEM Meeting in Georgia in October.

The therapy demonstrated superior efficacy in combination with SOC over SOC alone.

Concomitantly, other treatment modalities such as physical and occupational therapy, anticonvulsants, topical analgesics, and psychosocial treatment have increased.

Calabrese discussed the multi-faceted role of viral infections in the field of rheumatology ahead of the 2024 CCR West meeting.

BIMZELX was previously approved for treating moderate-to-severe plaque psoriasis.

Gender, age, and disease duration significantly affected symptom variations.

Extended follow-up with more cases is ongoing and will allow risk factors for psoriatic arthritis to also be further explored.

The model gave special emphasis to words noting pain, fatigue and depressed moods.

The increase will largely be driven by population growth and aging.

Digital ACT demonstrated superiority over active control in a number of outcomes in a phase 3 trial.

There were also no significant differences in clinical parameters at baseline for patients initiating first-line or not first-line therapy.

All patients had persistent tumor responses, with 2 complete responses and 1 case of stable disease.

Types of occupation did not significantly affect response to treatment.

Patients also experienced a substantial decrease in systolic blood pressure and diastolic blood pressure.

Notably, people with fewer vaccine doses were more likely to experience post-acute sequelae of COVID-19.

There were no differences in risk between patients with RA or PsA using or not using methotrexate.

Hs-cTnT was found to be associated with a higher risk of MACE and all-cause mortality in a 10-year cohort study.

Substitutors also reported fewer adverse events and greater social acceptance with MC.

In general, current drinkers had a higher risk than never drinkers among men but not women.

There may be a relationship between the inflammatory processes of fibromyalgia and celiac disease.

Wells discussed the PrismRA blood test, which may benefit planning treatment regimens for patients with rheumatic disease.

Although only 9 patients with FM and nasal septum deviation were included in the study, none met the criteria for fibromyalgia after surgery.

Wells discussed the importance and recommended frequency for several factors, including lipid panels, chest X-rays, pregnancy tests, and flu vaccines.

Patients with high RF concentration treated with CZP were more likely to achieve DAS28-CRP low disease activity at week 104 than those treated with adalimumab.

Investigators analyzed levels of CXCL10, MMP3, S100A8, ACP5, and CCL2 in patients treated with biologics and methotrexate.